Tandem and JDRF have entered into an agreement to develop a dual hormone pump.
SAN DIEGO, Jan. 8, 2013 /PRNewswire via COMTEX/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin.Looks a lot like a JDRF IDDP. Has all the right words, performance based milestones etc, just not the IDDP letter. Full test here: